Lantern Pharma Inc. Files 8-K on Executive & Corporate Changes
Ticker: LTRN · Form: 8-K · Filed: Jul 29, 2025 · CIK: 1763950
| Field | Detail |
|---|---|
| Company | Lantern Pharma Inc. (LTRN) |
| Form Type | 8-K |
| Filed Date | Jul 29, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-changes, filing
TL;DR
Lantern Pharma filed an 8-K detailing director/officer changes and corporate updates as of July 24, 2025.
AI Summary
Lantern Pharma Inc. filed an 8-K on July 29, 2025, reporting events as of July 24, 2025. The filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. It also includes amendments to articles of incorporation or bylaws, a change in fiscal year, and financial statements and exhibits.
Why It Matters
This 8-K filing indicates significant corporate governance and potential executive changes at Lantern Pharma, which could impact the company's strategic direction and operational leadership.
Risk Assessment
Risk Level: medium — Changes in directors, officers, and corporate structure can signal shifts in strategy or internal dynamics that may affect future performance.
Key Players & Entities
- Lantern Pharma Inc. (company) — Registrant
- July 24, 2025 (date) — Date of earliest event reported
- July 29, 2025 (date) — Date of report
FAQ
What specific changes occurred regarding directors or officers?
The filing indicates events related to the departure of directors or certain officers, election of directors, and appointment of certain officers.
Were there any changes to Lantern Pharma's compensatory arrangements?
Yes, the filing explicitly mentions 'Compensatory Arrangements of Certain Officers' as an item of report.
Did Lantern Pharma amend its articles of incorporation or bylaws?
The filing includes 'Amendments to Articles of Incorporation or Bylaws' as an item of report.
Is there a change in Lantern Pharma's fiscal year?
Yes, the filing lists 'Change in Fiscal Year' as an item of report.
What financial information is included in this filing?
The filing includes 'Financial Statements and Exhibits'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 29, 2025 regarding Lantern Pharma Inc. (LTRN).